Two cases of linear IgA disease with clinical manifestations limited to the gingiva

Journal of Periodontology

Volumn 74, Issue 6, 2003, Pages 879-882

  del Valle, A Eguia ^a   Martiinez Sahuquillo A ^b   Armas Padron J R ^b   Aguirre Urizar, José M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Autoantibodies; Autoimmune disorders; Blistering diseases; Bullae; Gingivitis, desquamative; IgA disease, linear

Indexed keywords

CHLORHEXIDINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; DAPSONE; DOXYCYCLINE; IMMUNOGLOBULIN A; MICONAZOLE; PREDNISONE; TRIAMCINOLONE;

ADULT; AGED; ANEMIA; ARTICLE; BASEMENT MEMBRANE; BLOOD TOXICITY; BULLOUS SKIN DISEASE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; DRUG DOSE REDUCTION; FEMALE; GINGIVA DISEASE; HUMAN; HYPERBILIRUBINEMIA; IMMUNOGLOBULIN DEPOSITION; MALE; MOUTH LESION; MOUTH MUCOSA; THROMBOCYTOPENIA;

EID: 0037960846     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2003.74.6.879     Document Type: Article

References (28)

1. Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:517-534.
2. Ahkami R, Thomas I. Linear IgA bullous dermatosis associated with vancomycin and diseminated varicellazoster infection. Cutis 2001;67:423-426.
3. Wiadrowski TP, Reid CM. Drug-induced linear IgA bullous disease following antibiotics. Autralas J Dermatol 2001;42:196-199.
4. Danielsen AG, Thomsen K. Vancomycin-induced linear IgA bullous disease. Br J Dermatol 1999;141:756-757.
5. Girao L, Fiadeiro T, Rodriges JC. Burn-induced linear IgA dermatosis. J Eur Acad Dermatol Venereol 2000;14: 507-510.
6. Van Der Wall RI, Van De Scheur MR, Pas HH, et al. Linear IgA bullous dermatosis in a patient with renal cell carcinoma. Br J Dermatol 2001;144:870-873.
7. Stuber E, Swensson O, Nitsche R, et al. Association of lymphocytic colitis with linear IgA dermatosis. Z Gastroenterol 1999;37:519-523.
8. Wong DA, Hunt MJ, Stapleton K. IgA multiple myeloma presenting as an acquired bullous disorder. Australas J Dermatol 1999;40:31-34.
9. Weisenfeld D, Martín A, Scully C, Thomson J. Oral manifestations in linear IgA disease. Br Dent J 1982; 153:398-399.
10. Chan LS, Regezi JA, Cooper KD. Oral manifestations of linear IgA disease. J Am Acad Dermatol 1990;22: 362-365.
11. Kelly SE, Frith PA, Millard PR, Wojnarowska F, Black MM. A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol 1988;119:161-170.
12. Williams DM. Non-infectious diseases of the oral soft tissue: A new approach. Adv Dent Res 1993;7:213-219.
13. Cohen DM, Bhattacharyya I, Zunt SL, Tomich CE. Linear IgA disease histopathologically and clinically masquerading as lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:196-201.
14. Porter SR, Scully C, Midda M, Eveson JW. Adult linear immunoglobulin A disease manifesting as desquamative gingivitis. Oral Surg Oral Med Oral Pathol 1990;70:450-453.
15. Porter SR, Bain SE, Scully C. Linear IgA disease manifesting as recalcitrant desquamative gingivitis. Oral Surg Oral Med Oral Pathol 1992;74:179-182.
16. Georgi M, Scheckenbach C, Kromminga A, et al. Mapping of etiotopes on the BP 180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease. Arch Dermatol Res 2001;293:109-114.
17. Christophoridis S, Budinger L, Borradori L, Hunziker T, Merk HF, Hertl M. IgG, IgA and IgE autoantibodies against the ectodomain of BP 180 in patients with bullous and cicatricial pemphigoid and linear IgA dermatosis. Br J Dermatol 2000;143:349-355.
18. Roh JY, Yee C, Lazarova Z, Hall RP, Yancey KB. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Br J Dermatol 2000;143:104-111.
19. Fujimoto W, Ohtsu T, Toi Y, Nakanishi G, Arata J. Linear IgA disease with IgA antibodies directed against 200- and 280-kDa epidermal antigens. Br J Dermatol 2000;142:1213-1218.
20. Zillikens D. Acquired skin disease of hemidesmosomes. J Dermatol Sci 1999;20:134-154.
21. Zillikens D, Giudice GJ. BP 180/type XVII collagen: Its role in acquired and inherited disorders of the dermal-epidermal junction. Arch Dermatol Res 1999;291:187-194.
22. Cowan CG, Lamey PJ, Walsh M, Irwin ST, Allen G, McKenna KE. Linear IgA disease (LAD): Immunoglobulin deposition in oral and colonic lesions. J Oral Pathol Med 1995;24:374-378.
23. Caproni M, Rolfo S, Bernacchi E, Bianchi B, Brazzini B, Fabbri P. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of IgA bullous dermatosis. Br J Dermatol 1999;140:1072-1078.
24. McFadden JP, Leonard JN, Powles AV, Rutman AJ, Fry L. Sulpamethoxypyridazine for dermatitis heretiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 1989;121:759-762.
25. Young HS, Coulson IH. Linear IgA disease: Successful treatment with cyclosporin. Br J Dermatol 2000;143:204-205.
26. Korman NJ. New and emerging therapies in the treatment of blistering diseases. Dermatol Clin 2000;18:127-137.
27. Ang P, Tay YK. Treatment of linear IgA bullous dermatosis of childhood with colchicine. Pediatr Dermatol 1999;16:50-52.
28. Jablonska S. The therapies for linear IgA bullous dermatosis of childhood. Pediatr Dermatol 1999;16:415.